HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert M Straubinger Selected Research

birinapant

10/2020Pharmacodynamic modeling of synergistic birinapant/paclitaxel interactions in pancreatic cancer cells.
10/2018Physiologically-based pharmacokinetic and pharmacodynamic models for gemcitabine and birinapant in pancreatic cancer xenografts.
1/2018Proteomic Analysis of Combined Gemcitabine and Birinapant in Pancreatic Cancer Cells.
1/2018Multi-Scale Network Model Supported by Proteomics for Analysis of Combined Gemcitabine and Birinapant Effects in Pancreatic Cancer Cells.
1/2018Temporal Effects of Combined Birinapant and Paclitaxel on Pancreatic Cancer Cells Investigated via Large-Scale, Ion-Current-Based Quantitative Proteomics (IonStar).
10/2015Mechanism-based mathematical modeling of combined gemcitabine and birinapant in pancreatic cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert M Straubinger Research Topics

Disease

36Neoplasms (Cancer)
05/2022 - 05/2002
19Pancreatic Neoplasms (Pancreatic Cancer)
05/2022 - 01/2013
7Brain Neoplasms (Brain Tumor)
01/2017 - 05/2002
6Adenocarcinoma
10/2020 - 05/2013
5Hemophilia A (Haemophilia)
01/2012 - 04/2008
4Glioma (Gliomas)
01/2017 - 01/2015
2Breast Neoplasms (Breast Cancer)
03/2018 - 01/2013
2Hemorrhage
01/2012 - 04/2008
2Gliosarcoma
02/2010 - 05/2002
2Ovarian Neoplasms (Ovarian Cancer)
11/2008 - 09/2002
1Biliary Tract Neoplasms (Biliary Tract Cancer)
01/2019
1Cardiotoxicity
03/2018
1Infections
01/2017
1Cocaine-Related Disorders (Cocaine Addiction)
01/2016
1Drug-Related Side Effects and Adverse Reactions
03/2014
1Hepatocellular Carcinoma (Hepatoma)
05/2013
1Renal Cell Carcinoma (Grawitz Tumor)
05/2013
1Neutropenia
10/2012
1Non-Hodgkin Lymphoma (Lymphosarcoma)
04/2012
1Tuberculosis (Tuberculoses)
07/2007

Drug/Important Bio-Agent (IBA)

23Pharmaceutical PreparationsIBA
05/2022 - 03/2004
12Liposomes (Liposome)IBA
05/2022 - 05/2002
11Paclitaxel (Taxol)FDA LinkGeneric
10/2020 - 09/2002
10GemcitabineFDA Link
01/2021 - 09/2013
7Doxorubicin (Adriamycin)FDA LinkGeneric
03/2018 - 05/2002
6birinapantIBA
10/2020 - 10/2015
4Drug CarriersIBA
10/2020 - 03/2004
4Factor VIII (Coagulation Factor VIII)IBA
01/2012 - 04/2008
3Cetuximab (Erbitux)FDA Link
11/2020 - 11/2019
32- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
10/2020 - 10/2019
3ProteomeIBA
11/2018 - 01/2013
3Proteins (Proteins, Gene)FDA Link
01/2018 - 07/2007
3Antineoplastic Agents (Antineoplastics)IBA
03/2014 - 03/2010
3Sorafenib (BAY 43-9006)FDA Link
05/2013 - 01/2013
3Phosphotransferases (Kinase)IBA
05/2013 - 08/2012
3EverolimusFDA Link
05/2013 - 01/2013
2Immunoconjugates (Immunoconjugate)IBA
11/2020 - 11/2019
2CamptothecinIBA
10/2020 - 11/2019
2AntibodiesIBA
11/2019 - 11/2019
2ErbB Receptors (EGF Receptor)IBA
11/2019 - 08/2012
2Drug CombinationsIBA
11/2019 - 01/2018
2Epidermal Growth Factor (EGF)IBA
03/2018 - 08/2012
2Inhibitor of Apoptosis ProteinsIBA
01/2018 - 10/2015
2MicellesIBA
01/2017 - 01/2016
2TrabectedinIBA
01/2016 - 01/2016
2TOR Serine-Threonine KinasesIBA
05/2013 - 01/2013
2liposomal doxorubicin (Doxil)FDA Link
01/2013 - 12/2012
2Phosphatidylinositols (Phosphatidylinositol)IBA
01/2012 - 09/2010
2Neutralizing AntibodiesIBA
01/2012 - 02/2011
2PhosphatidylserinesIBA
02/2011 - 04/2008
1Irinotecan (Camptosar)FDA LinkGeneric
05/2022
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
01/2021
1auristatinIBA
11/2020
1CaspasesIBA
10/2020
1DNA (Deoxyribonucleic Acid)IBA
10/2020
1Caspase 8 (Caspase-8)IBA
10/2020
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
10/2020
1Ado-Trastuzumab EmtansineIBA
11/2019
1Growth Factor ReceptorsIBA
11/2019
1sonidegibIBA
11/2019
14- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA
01/2019
1Capecitabine (Xeloda)FDA Link
01/2019
1Trastuzumab (Herceptin)FDA Link
03/2018
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2018
1Fatty Acids (Saturated Fatty Acids)IBA
01/2018
1histidine-rich proteinsIBA
01/2018
1Insulin-Like PeptidesIBA
01/2018
1130-nm albumin-bound paclitaxelIBA
01/2018
1Somatomedin Receptors (Somatomedin Receptor)IBA
01/2018
1Neuregulin-1 (Neuregulin 1)IBA
01/2018
1IstiratumabIBA
01/2018
1RNA (Ribonucleic Acid)IBA
01/2017
1Epithelial Cell Adhesion MoleculeIBA
01/2017
1Peptides (Polypeptides)IBA
01/2017
1Small Nucleolar RibonucleoproteinsIBA
01/2017
1LipidsIBA
01/2016
1Cocaine (Cocaine HCl)IBA
01/2016
1Cytostatic AgentsIBA
10/2015
1Cytotoxins (Cytolysins)IBA
10/2015
1Immunosuppressive Agents (Immunosuppressants)IBA
05/2013
1Tyrosine Kinase InhibitorsIBA
01/2013
1Lapatinib (GW572016)FDA Link
01/2013
1cadherin 5IBA
12/2012
1Angiogenesis InhibitorsIBA
12/2012
1Tyrosine (L-Tyrosine)FDA Link
08/2012
1RetinoidsIBA
04/2012
1Rituximab (Mabthera)FDA Link
04/2012
1FenretinideIBA
04/2012
1TNF-Related Apoptosis-Inducing LigandIBA
04/2012
1SDMIBA
03/2010
1cremophor ELIBA
02/2010
1Ethanol (Ethyl Alcohol)IBA
02/2010
1Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
09/2008

Therapy/Procedure

15Therapeutics
11/2020 - 03/2004
5Drug Therapy (Chemotherapy)
03/2018 - 09/2002
4Intra-Arterial Injections
01/2017 - 01/2015
2Lasers (Laser)
05/2022 - 10/2019
2Combination Drug Therapy (Combination Chemotherapy)
10/2015 - 04/2012
1Photochemotherapy (Photodynamic Therapy)
05/2022
1Intravenous Administration
02/2010